Brad

@ThinkingBitmex Always finding something to bitch about.

Imagine what happens when he says "This week we sold Bitcoin" Saylor's debt problem is real That being said he has no reason to sell in the next 1-2 years

@sayinshallah Great bottom signal lol. Usually what a cuck would say

Bitcoin has truly lost all its value and just became a speculative asset that Saylor bids up, but that ship has now sailed. Nobody wants to buy or bid bitcoin anymore. If you haven’t made it yet in crypto, don’t bother. It’s over.

@PlayTechHD @choquei Only thing that couldve killed him is insulin

@choquei como assim faleceu o gabriel ganley?

🚨AGORA: Morre Gabriel Ganley, fisiculturista brasileiro, aos 22 anos.

@tmaxftw LOL the SP500 haha

Bitcoin won’t bull run again until Saylor goes bankrupt. It’s also now 15-yr old legacy tech and getting more legacy by the second.

@Snz_BTC Lol you were just the byproduct of his intentions with the video. The fact that you posted it means he outsmarted you. I think youre clown.

Turning the resistance money into a clown show

@_TrueVoodoo When you first tried it, how pronounced were the effects how how it "Felt". I'm on .5 a week but titrating eventually up to 2 mg and I don't feel much. A little less food noise but nothing thats that "woah"

When it comes to using Reta… I know a few things.

@BigpictureBTC You have no idea what the fuck youre talking about. Stop talking out of your ass

$STRC is hitting an inevitable structural ceiling. Demand exhaustion and diminishing buying volume over the last month have left it defenseless against post-ex-dividend selling pressure. Why? 1. Cash reserves are bleeding fast, now down to just 15 months. The weight of scale-driven dilution and looming BTC sale requirements is finally closing in, and the market can smell it. 2. The “HODL forever” narrative that secured the majority of Saylor's capital is about to break. 3. Bitcoin simply isn't performing well enough to mask the scale-driven cracks in Saylor’s model, cracks that have now become structural. In my view, Strategy’s approach has partially fueled Bitcoin’s underperformance by wrapping it inside the exact same debt-driven, dilution-heavy fiat system it was built to escape. Honestly, it's the inevitable fallout of the first iteration of Bitcoin in traditional capital markets. The good news is the second iteration will truly reflect Bitcoin’s principles, optimise shareholder value, and contribute to its necessary evolution into a global monetary network.

@4score__7 @dividendology lol this is probably why your network is under 300 grand.

@dividendology Yep. Pretty easy, actually. Buy a home outright for $500k. That leaves $1.5MM. Invest it into something low risk like SGOV. Earns about 3.75% right now. That’s $56k per year. Let’s call it $4k a month, net of taxes. I’ll need health insurance, as not old enough for Medicare

Do you think you could retire forever on $2,000,000?

@BenPhiat Yeah for 1 minute

I love it when $SATA is over $100

@cullenroche No one is asking you this. lol

Everyone keeps me asking me how I'm a stressed out workaholic with a dad bod. Here are my 7 key tips: ....

@dividendology This is fucking bullshit, top 1% is not that high.

Here are the net worth brackets by age in 2023: Note: This is based on the Federal Reserve's 2022 Survey of Consumer Finances (most recent available)

@DesingerGem @UncleSemite @bryan_johnson Not sure if m1 is fda approved. Just depends on what your skin type is and if you monitor any possible growths closely and go regularly to a dermatologist

@Yield_Strat @UncleSemite @bryan_johnson I see but mt 2 isnt safe I think wnf mt 1 is fda approved isnt it?

People mistakenly believe peptides are only good. Peptides can be bad, too. They can cause adverse effects. Some dangerous. I did a peptide experiment and measured its effects in my body. The results are complicated. I tried a peptide called CJC-1295. It pushed my growth hormone up by ~8x. That’s good. That’s what it was supposed to do. But, it also came with adverse effects: > increased my morning fasted blood sugar up 20% > increased stress hormone by 12% > tanked my REM sleep by 23% > made my pancreas work 53% harder and was still losing to rising blood glucose > increased my insulin resistance by 50% These were the most obvious side effects, and I only ran a very narrow panel for this experiment. So I’m sure there’s more. I stopped after two doses, without even reaching the intended target dose. For those of you new to peptides, your body sends instructions to itself using tiny chemical messengers called peptides. There are thousands of them. For example, GLP-1s are drugs that take an existing class of short-lived peptides and modify them to extend their activity duration, which turns them into drugs, following rigorous clinical testing. CJC-1295 is one of those peptide-drugs. It tells your brain to release more growth hormone. Growth hormone is your body's signal to build muscle, repair tissue, and recover. However, and like most grey market peptides, CJC-1295 did not succeed its clinical trial, and hence never became an “official” drug. There is a version called CJC-1295 with DAC. DAC is an attachment glued onto the peptide that makes it last for days in your body instead of hours. One shot, longer effect, just like GLP-1s. Why people use it: more growth hormone could mean better recovery, leaner body, faster healing. The experiment I completed. Two injections a week of CJC-1295 with DAC: > 1.2 mg > 1.8 mg 48 hours after the first injection I was nearly comatose. It felt like severe jet lag, the type you’d feel after traveling nine time zones. My sleep was wrecked and I felt continuously awful. My REM sleep dropped by 23%. REM is when your brain processes memories and repairs itself. Less time for my brain to repair itself. During the experiment, I never felt rested and always fatigued. Why we chose CJC-1295 with DAC. Some will say we picked the wrong peptide. They will say I should have used a different version, CJC-1295 without DAC, mixed with another peptide called Ipamorelin. We went with CJC-1295 with DAC instead as it has the most controlled studies. CJC-1295 with DAC has 2 controlled trials in healthy adults. Ipamorelin alone has 1 controlled trial in healthy adults, plus 1 study that failed when they tried it on bowel surgery patients. The mix of the two has zero controlled trials. On Ipamorelin, it copies a chemical called ghrelin, the one that makes you hungry. On its own it gives you a quick burst of growth hormone that fades fast. It does not keep your longer acting growth signal (called IGF-1) up. Clinics mix Ipamorelin with CJC-1295 no-DAC because the two together are supposed to work better. But we don’t know if that’s accurate because we don’t have trial data. This is a problem with peptides. Almost none of them have been tested properly. We are flying blind. Most of what people use is based on what someone said online, what a clinic claims, or what a friend reports from their subjective feelings. Peptides have the potential to be great when well-studied.

@DeFi_initiate The selling 100,000.00 in bitcoin will allow him to boy 900,000.00 in bitcoin through his preferreds. It actually helps him accumulate more. Its net accretive

Saylor never understood the cyclical nature of Bitcoin, which is why he is now in a bind. The next 6 months will be rough.

@DesingerGem @UncleSemite @bryan_johnson Never taken m1 just because you have to load way more. It’s a little safer but you can’t achieve the same results as M2

@UncleSemite @Yield_Strat @bryan_johnson What about melanotan 1?

@UncleSemite @bryan_johnson Once a year. Everything checks out

@bryan_johnson @damoosmann So one participant and a couple data points draws this conclusion. Learn statistics. You’re worth half a billion dollars, surely you can run a study with more volunteers. This is amatuer science. It’s to be discredited.

@damoosmann We actually started lower than the minimum active dose based on clinical data, while GH baseline increased, no IGF-1 increase is detected, confirming the dose was still on the lower end, yet causing many adverse effects.

@Strike @jackmallers @TheBitcoinConf 7.49 is still shit, get to sub 5.5 and you’ll have a chance

@RobLipsett Weird flex bro

First of many yacht days this season Marbella summer is undefeated

Strategy is proposing to pay semi-monthly dividends on $STRC, instead of monthly. No change to the annual dividend obligations or dividend rate. These proposed changes are intended to stabilize price, dampen cyclicality, drive liquidity, and grow demand.